Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence

Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Antonio Spanevello, Giovanni Battista Migliori on behalf of the International Group for the study of Linezolid
European Respiratory Journal 2013 42: 288-290; DOI: 10.1183/09031936.00191712

Article Information

vol. 42 no. 1 288-290
DOI 
https://doi.org/10.1183/09031936.00191712
PubMed 
23813314
Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received November 26, 2012
  • Accepted December 24, 2012
  • Published online June 30, 2013.
Copyright & Usage 
©ERS 2013

Author Information

  1. Giovanni Sotgiu1,
  2. Rosella Centis2,
  3. Lia D'Ambrosio2,
  4. Antonio Spanevello3 and
  5. Giovanni Battista Migliori2⇑
  6. on behalf of the International Group for the study of Linezolid4
  1. 1Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari
  2. 2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate
  3. 3Università degli Studi dell'Insubria, Varese, and Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
  4. 4A full list of the International Group for the study of Linezolid members and their affiliations can be found in the acknowledgements section
  1. G.B. Migliori, S. Maugeri Foundation, Via Roncaccio 16, Tradate, Varese, Italy. E-mail: giovannibattista.migliori{at}fsm.it
View Full Text

Article usage

Article usage: June 2013 to August 2021

AbstractFullPdf
Jun 20133917
Jul 20135122964
Aug 2013421024
Sep 201337912
Oct 20134588
Nov 20132725
Dec 20131694
Jan 20141732
Feb 2014172215
Mar 20142468
Apr 20141559
May 20141736
Jun 20142167
Jul 20142244
Aug 2014776
Sep 2014131013
Oct 20149810
Nov 2014141011
Dec 2014121512
Jan 20156138
Feb 2015863
Mar 201512125
Apr 2015112411
May 2015791
Jun 20153118
Jul 20156135
Aug 20156165
Sep 2015755
Oct 201520103
Nov 20154163
Dec 201551516
Jan 201661810
Feb 201641111
Mar 201682214
Apr 20166117
May 2016121716
Jun 2016122511
Jul 201692811
Aug 201661620
Sep 2016102220
Oct 20163209
Nov 2016112517
Dec 20164210
Jan 20173292
Feb 20175244
Mar 20175308
Apr 20170221
May 20172308
Jun 20176260
Jul 20172225
Aug 201722311
Sep 20172366
Oct 201712912
Nov 20170175
Dec 20172185
Jan 20181125
Feb 201812112
Mar 20183289
Apr 201814110
May 20183447
Jun 20180537
Jul 201813210
Aug 20180397
Sep 20180234
Oct 20180212
Nov 20180255
Dec 20180144
Jan 20190284
Feb 20191275
Mar 20191307
Apr 20191205
May 20191124
Jun 20190177
Jul 201934214
Aug 20194327
Sep 20191324
Oct 201932110
Nov 20192267
Dec 20191159
Jan 20201106
Feb 202011810
Mar 20205185
Apr 20202149
May 20200166
Jun 20200104
Jul 202001810
Aug 202052116
Sep 202042810
Oct 20203325
Nov 20202137
Dec 20204355
Jan 20210144
Feb 20212918
Mar 20215254
Apr 202134115
May 20211329
Jun 20211262
Jul 20213137
Aug 202124210

Altmetrics

Back to top
View this article with LENS
Email
Print
Alerts
Citation Tools

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence
Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Antonio Spanevello, Giovanni Battista Migliori
European Respiratory Journal Jul 2013, 42 (1) 288-290; DOI: 10.1183/09031936.00191712
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

Subjects